AR095833A1 - Procedimiento para la preparación de drospirenona - Google Patents
Procedimiento para la preparación de drospirenonaInfo
- Publication number
- AR095833A1 AR095833A1 ARP140101552A ARP140101552A AR095833A1 AR 095833 A1 AR095833 A1 AR 095833A1 AR P140101552 A ARP140101552 A AR P140101552A AR P140101552 A ARP140101552 A AR P140101552A AR 095833 A1 AR095833 A1 AR 095833A1
- Authority
- AR
- Argentina
- Prior art keywords
- drospirenone
- preparation
- formula
- dimethylene
- procedure
- Prior art date
Links
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 title abstract 3
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 title abstract 3
- 229960004845 drospirenone Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 abstract 1
- 229940083712 aldosterone antagonist Drugs 0.000 abstract 1
- 230000002280 anti-androgenic effect Effects 0.000 abstract 1
- 230000001327 anti-mineralocorticoid effect Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002254 contraceptive effect Effects 0.000 abstract 1
- 239000002394 mineralocorticoid antagonist Substances 0.000 abstract 1
- 239000002808 molecular sieve Substances 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000002941 palladium compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000757 progestagenic effect Effects 0.000 abstract 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Gynecology & Obstetrics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Abstract
La drospirenona es un esteroide sintético con actividad progestogénica, antimineralocorticoide y antiandrogénica útil para la preparación de composiciones farmacéuticas de acción anticonceptiva. Reivindicación 1: Procedimiento para la preparación de drospirenona de fórmula (1) comprende la transformación en una única operación de un compuesto elegido entre 17a-(3-hidroxipropil)-6b,7b;15b,16b-dimetilen-5b-androstan-3b,5,17b-triolo dfe fórmula (2) por si solo o mezclado con sus lactoles y 3b,5-dihidroxi 6b,7b;15b,16b-dimetilen-5b,17a-pregna-21,17-carbolactona de fórmula (3), con oxígeno gaseoso en presencia de un compuesto de paladio en estado de oxidación +2, una base orgánica y tamices moleculares en un solvente orgánico inerte en las condiciones de reacción, a una temperatura comprendida entre 60 y 140ºC.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2013/052918 WO2014167386A1 (en) | 2013-04-12 | 2013-04-12 | Process for the preparation of drospirenone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR095833A1 true AR095833A1 (es) | 2015-11-11 |
Family
ID=48539320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140101552A AR095833A1 (es) | 2013-04-12 | 2014-04-11 | Procedimiento para la preparación de drospirenona |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9556220B2 (es) |
| EP (1) | EP2984100B1 (es) |
| JP (1) | JP6469078B2 (es) |
| CN (1) | CN105164144B (es) |
| AR (1) | AR095833A1 (es) |
| BR (1) | BR112015025816B1 (es) |
| CA (1) | CA2909087C (es) |
| DK (1) | DK2984100T3 (es) |
| ES (1) | ES2630331T3 (es) |
| HU (1) | HUE032858T2 (es) |
| MX (1) | MX356791B (es) |
| PL (1) | PL2984100T3 (es) |
| PT (1) | PT2984100T (es) |
| WO (1) | WO2014167386A1 (es) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3042136A1 (de) | 1980-11-03 | 1982-06-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden |
| DE3265852D1 (en) | 1981-09-21 | 1985-10-03 | Schering Ag | 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation |
| DE19633685C1 (de) * | 1996-08-12 | 1997-10-09 | Schering Ag | Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens |
| JP4645779B2 (ja) * | 2000-05-16 | 2011-03-09 | 日産化学工業株式会社 | キノリンカルボアルデヒドの製造法 |
| ITMI20040367A1 (it) * | 2004-03-01 | 2004-06-01 | Ind Chimica Srl | Processo per la preparazione di drospirenone |
| ITMI20042338A1 (it) * | 2004-12-06 | 2005-03-06 | Ind Chimica Srl | Processo per la preparazione di drospirenone |
| PL1746101T5 (pl) * | 2005-07-21 | 2014-11-28 | Bayer Pharma AG | Sposób wytwarzania 3-oksopreg-4-eno-21,17-karbolaktonów drogą bezmetalowego utleniania 17-(3-hydroksypropylo-3,17-dihydroksyandrostanu |
| CN100480256C (zh) * | 2006-06-21 | 2009-04-22 | 上海迪赛诺医药发展有限公司 | 合成曲螺酮的方法 |
| EP2057182A2 (en) * | 2007-05-01 | 2009-05-13 | Sicor, Inc. | A process for preparing drospirenone and intermediate thereof |
| ES2355586T3 (es) * | 2007-07-26 | 2011-03-29 | Newchem S.P.A. | Procedimiento de preparación de drospirenona. |
| CN101503455B (zh) | 2009-03-11 | 2011-02-16 | 药源药物化学（上海）有限公司 | 一种制备屈螺酮的方法及中间体 |
| ES2432063T3 (es) * | 2009-06-16 | 2013-11-29 | Crystal Pharma, S.A.U. | Procedimiento para la obtención de 17-espirolactonas en esteroides |
| ES2419663T3 (es) * | 2010-08-03 | 2013-08-21 | Newchem S.P.A. | Métodos para la preparación de Drospirenona y productos intermedios de la misma |
-
2013
- 2013-04-12 PL PL13726285T patent/PL2984100T3/pl unknown
- 2013-04-12 MX MX2015014331A patent/MX356791B/es active IP Right Grant
- 2013-04-12 PT PT137262853T patent/PT2984100T/pt unknown
- 2013-04-12 US US14/783,830 patent/US9556220B2/en active Active
- 2013-04-12 WO PCT/IB2013/052918 patent/WO2014167386A1/en active Application Filing
- 2013-04-12 HU HUE13726285A patent/HUE032858T2/en unknown
- 2013-04-12 CN CN201380075453.4A patent/CN105164144B/zh active Active
- 2013-04-12 JP JP2016507067A patent/JP6469078B2/ja active Active
- 2013-04-12 ES ES13726285.3T patent/ES2630331T3/es active Active
- 2013-04-12 BR BR112015025816-6A patent/BR112015025816B1/pt active IP Right Grant
- 2013-04-12 CA CA2909087A patent/CA2909087C/en active Active
- 2013-04-12 EP EP13726285.3A patent/EP2984100B1/en active Active
- 2013-04-12 DK DK13726285.3T patent/DK2984100T3/en active
-
2014
- 2014-04-11 AR ARP140101552A patent/AR095833A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE032858T2 (en) | 2017-11-28 |
| ES2630331T3 (es) | 2017-08-21 |
| US20160052960A1 (en) | 2016-02-25 |
| CN105164144A (zh) | 2015-12-16 |
| MX356791B (es) | 2018-06-12 |
| BR112015025816A2 (pt) | 2017-07-25 |
| EP2984100A1 (en) | 2016-02-17 |
| CA2909087C (en) | 2020-01-07 |
| CN105164144B (zh) | 2017-03-08 |
| DK2984100T3 (en) | 2017-07-10 |
| CA2909087A1 (en) | 2014-10-16 |
| JP6469078B2 (ja) | 2019-02-13 |
| JP2016516095A (ja) | 2016-06-02 |
| MX2015014331A (es) | 2015-12-08 |
| US9556220B2 (en) | 2017-01-31 |
| EP2984100B1 (en) | 2017-04-05 |
| BR112015025816B1 (pt) | 2021-02-02 |
| WO2014167386A1 (en) | 2014-10-16 |
| PL2984100T3 (pl) | 2017-10-31 |
| PT2984100T (pt) | 2017-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015025238A2 (pt) | composição contendo trifluoroetileno | |
| PH12021550049A1 (en) | Selective estrogen receptor degraders. | |
| EA201990565A1 (ru) | Кристаллический 19-нор c3,3-дизамещенный c21-n-пиразолил стероид | |
| CR20210006A (es) | Degradadores selectivos del receptor de estrógeno | |
| NZ744516A (en) | Selective estrogen receptor degraders and uses thereof | |
| CR10976A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso | |
| CU24337B1 (es) | Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrógenos | |
| CL2007001581A1 (es) | Proceso de preparacion de 6b,7b,15b,16b-dimetilen-3-oxo-17apregn-4eno-21,17-carbolactona (drospirenona) por oxidacion del correspondiente 3b,5,17b-triol usando un catalizador del tipo 2,2,6,6-tetrametilpiperidin-1oxilo en presencia de un acido. | |
| HK1201274A1 (en) | 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof 33- 19- | |
| DOP2011000402A (es) | Composicion farmaceutica para la anticoncepcion de emergencia | |
| CL2012002124A1 (es) | Polvo de rifaximina que comprende un tamaño de partícula entre 40 y 120 micrómetros; composiciones de liberacion controlada que contienen dicha rifaximina y su proceso de preparación, util para el tratamiento de infección intestinales bacterianas.. | |
| CL2012000450A1 (es) | Compuestos derivados de isoxazolidina de glucocorticoides, de la serie de los glucocorticoides; composicion farmaceutica; combinacion farmaceutica; proceso para su preparacion; y uso para disminuir la cantidad, acividad y movimiento de las celulas inflamatorias. | |
| BR112012033391A2 (pt) | kit contraceptivo, método contraceptivo para uma paciente do sexo feminino necessitando do mesmo e composição farmacêutica compreendendo drospirenova. | |
| CL2008003802A1 (es) | Compuestos derivados de tioeteres c-21, agonistas del receptor de glucocorticoide; composicion farmaceutica; y uso para el tratamiento o profilaxis de una enfermedad o afeccion inmune, autoinmune o inflamatoria, tales como artritis reumatoide y esclerosis multiple. | |
| NZ600263A (en) | 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof | |
| ECSP088472A (es) | Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento | |
| ATE539082T1 (de) | Oxazinylisoflavonoidverbindungen, medikamente und anwendungen | |
| AR095833A1 (es) | Procedimiento para la preparación de drospirenona | |
| UY32005A (es) | Derivados de estratrieno que comprenden bioisósteros heterocíclicos para el anillo fenólico a | |
| BR112017005460A2 (pt) | síntese de estado sólido de catalisadores de desidrogenação oxidativa | |
| AR066415A1 (es) | Catalizador de deshidrogenacion, proceso de preparacion del mismo y proceso de deshidrogenacion de un hidrocarburo | |
| 冯书晓 et al. | Synthesis and Crystal Structure of a Novel 14, 20-Annulated Pentacyclic Steroid 17 (S)-Methyl-13β-hydroxyl-14 (R), 20 (S)-epoxy-pregn-4-en-3-one | |
| PE20020894A1 (es) | USO DE LIGANDOS SELECTIVOS PARA ERß PARA REGULAR LA FERTILIDAD | |
| FI20116033A (fi) | Uudet ei-steroidiset yhdisteet androgeenireseptorin muuntelijoina | |
| WO2010076811A3 (en) | Process for the preparation of exemestane |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |